Founded in 1851, Heraeus operates in precious metals, materials science, and technology. Its shares do not trade on a public exchange.
Heraeus has no published valuation.
No funding round for Heraeus has been disclosed yet.
No investor is named on the Heraeus record yet.
Heraeus develops materials used across smartphones, fiber optic cables, pacemaker components and bone cement, organizing its business into four areas: Precious Metals, Healthcare, Semiconductor & Electronics, and Industrials. The company traces its origin to platinum smelting, after founder Wilhelm Carl Heraeus worked out how to melt the metal in large volumes using an oxyhydrogen blowpipe he built himself.
Heraeus took its present form in Hanau, Germany, in 1851, growing out of a pharmacy the family had run since 1660, and remains one of Germany's largest family-owned companies by revenue. It employs 15,100 people in 40 countries and generated total revenue of €25.6 billion in 2023.
Listed funds carry late-stage private names. A fund's latest schedule of investments shows whether it holds Heraeus.
Often trade at a premium or discount to NAV.
Platforms match existing holders with buyers. Heraeus availability at any moment is set by the holders.
High minimums, transfer approval, company right-of-first-refusal.
Valuations, rounds and IPO status for every company in the directory — Heraeus included.
The routes section explains what is realistically available for a company at this stage.
No. Heraeus is a private company; its shares do not trade on a public exchange.
The closest precious metals, materials science, and technology peers are on the competitors page.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
